Imunon, Inc. Common Stock, Value, Issued
Imunon, Inc. (IMNN) had Common Stock, Value, Issued of $46.66 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-11
- 2026-06-30: Common Stock, Value, Issued $46.66K.
- 2026-03-31: Common Stock, Value, Issued $39.23K.
- 2025-12-31: Common Stock, Value, Issued $34.20K.
- 2025-09-30: Common Stock, Value, Issued $28.96K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $46.66K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $39.23K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $34.20K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $28.96K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $17.18K 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $146.21K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $9.67K 10-K · filed 2026-03-31 | $145.01K 10-K · filed 2025-02-27 |
| 2024-09-30 | $145.01K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $94.01K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $94.01K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $94.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $93.68K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $92.52K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $90.97K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $74.36K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $70.99K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $70.99K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $57.70K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $57.70K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $865.58K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $865.58K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $750.20K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $27.13K 10-K · filed 2022-03-31 | $407.01K 10-K · filed 2021-03-19 |
| 2020-09-30 | $361.60K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $332.30K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $292.57K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $232.56K 10-K · filed 2021-03-19 | |
| 2019-09-30 | $220.03K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $210.03K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $196.62K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $188.32K 10-K · filed 2020-03-25 | |
| 2018-09-30 | $179.11K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $177.47K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $177.40K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $172.77K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $83.56K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $59.15K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $554.71K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $22.30K 10-K · filed 2018-03-27 | $312.26K 10-K · filed 2017-03-24 |
| 2016-09-30 | $260.83K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $258.33K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $234.90K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $233.95K 10-K · filed 2017-03-24 | |
| 2015-09-30 | $231.12K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $230.99K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $200.98K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $200.98K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $200.97K 10-Q · filed 2014-11-10 | |
| 2013-12-31 | $137.38K 10-K · filed 2015-03-12 | |
| 2003-01-31 | $2.20M 10-K · filed 2018-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |